Translational Development Acquisition (TDACW) Total Current Liabilities (2023 - 2026)

Translational Development Acquisition (TDACW) has reported Total Current Liabilities for 4 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 515.27% year-over-year to $1.8 million; the trailing twelve-month figure through Jun 2026 stood at $1.8 million (up 515.27% YoY), and the FY2025 full-year result was $544073.0, up 158.71% from the prior year.
• Total Current Liabilities rose to $1.8 million in Q2 2026 per TDACW's latest filing, from $861085.0 in the prior quarter.
• Across five years, Total Current Liabilities topped out at $1.8 million in Q2 2026 and bottomed at $210303.0 in Q4 2024.
• Historically, Total Current Liabilities has averaged $613389.6 across 4 years, with a median of $466262.0 in 2023.
• The sharpest annual moves came in 2024 and 2026: Total Current Liabilities sank 58.74% in 2024, then soared 515.27% in 2026.
• Over 4 years, Total Current Liabilities stood at $509679.0 in 2023, then tumbled by 58.74% to $210303.0 in 2024, then jumped by 158.71% to $544073.0 in 2025, then soared by 221.93% to $1.8 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $1.8 million, $861085.0, and $544073.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.